Status:
UNKNOWN
Observational Study of the Sleuth Implantable ECG Monitoring System
Lead Sponsor:
Transoma Medical
Conditions:
Syncope
Presyncope
Eligibility:
All Genders
Brief Summary
The purpose of this study is to obtain information on real-world device performance clinical assessments and clinical outcomes of patients receiving the Sleuth Implantable ECG Monitoring System.
Eligibility Criteria
Inclusion
- Patients with clinical syndromes or situations at increased risk of cardiac arrhythmias
- Patients who experience transient symptoms that may suggest a cardiac arrhythmia
Exclusion
- Patients that have had a myocardial infarction (MI) \< 30 days prior to implant
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00717106
Start Date
July 1 2008
Last Update
May 5 2009
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Piedmont Hospital
Atlanta, Georgia, United States, 30309
2
Western Maryland Health Systems
Cumberland, Maryland, United States, 21502
3
Cardiology Consultants of East Michigan
Lapeer, Michigan, United States, 48446
4
St. Luke's - Roosevelt
New York, New York, United States, 10019